EW
PFE icon

Elyxium Wealth’s Pfizer PFE Stock Holding History

Elyxium Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$496K Buy
20,580
+4,161
+25% +$109K 0.05% 179
2026
Q1 		$461K Sell
16,419
-366
-2% -$9.74K 0.15% 104
2025
Q4 		$418K Sell
16,785
-5,446
-24% -$137K 0.12% 118
2025
Q3 		$566K Sell
22,231
-2,147
-9% -$53K 0.2% 89
2025
Q2 		$591K Sell
24,378
-868
-3% -$20.2K 0.22% 86
2025
Q1 		$640K Buy
25,246
+13,144
+109% +$344K 0.28% 73
2024
Q4 		$321K Sell
12,102
-22,468
-65% -$609K 0.2% 70
2024
Q3 		$1M Buy
+34,570
New +$1.01M 0.55% 40

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Elyxium Wealth's PFE Position: Q2 2026 in Review

Elyxium Wealth increased its Pfizer (PFE) stake by 25% in Q2 2026, buying an estimated $109K and bringing the position to 20,580 shares worth $496K. The position accounts for 0.05% of the portfolio, ranked #179.

Elyxium Wealth first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $1M in Q3 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Elyxium Wealth held 20,580 shares of Pfizer worth $496K as of Q2 2026.
  • Elyxium Wealth bought 4,161 Pfizer shares in Q2 2026, an estimated $109K.
  • Pfizer made up 0.05% of Elyxium Wealth's portfolio in Q2 2026, its #179 holding.
  • Elyxium Wealth first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
  • Elyxium Wealth's Pfizer position peaked at $1M in Q3 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Elyxium Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.